EDWARDS LIFESCIENCES, LLC for EDWARDS LIFESCIENCES LLC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Implementation of PL-111-148, Medical Device Tax Foreign Source Income Tax Deferral Taxation of Offshore Income Tax Reform Federal Corporate Tax Rate Repatriation Transfer Pricing R&D Tax Credit Domestic Manufacturing Credit H.R 160, Protect Medical Innovation Act of 2015 S. 149 Medical Device Access & Innovation Protection Act Patent Box
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH RAYE KEGLER | — |
| BARRY ROBERT LIDEN | — |
Medicare/Medicaid MMM
CMS Coverage Policies CMS Payment Policies H.R. 6, 21st Century Cures Act Senate Innovation Initiative
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH RAYE KEGLER | — |
| BARRY ROBERT LIDEN | — |
Health Issues HCR
Implementation of PL-111-148, Patient Protection and Affordable Care Act Implementation of PL-112-144, Food and Drug Administration Safety and Innovation Act Enhanced Surgical Recovery Protocols H.R. 6, 21st Century Cures Act Senate Innovation Initiative
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH RAYE KEGLER | — |
| BARRY ROBERT LIDEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.